78 Results for "

modest

" in MedChemExpress (MCE) Product Catalog:
Products (78)

78 Results for "modest" in MCE Product Catalog:

68
68 Publications Verification
Cat. No.: HY-50094
CAS No.: 957054-30-7
Synonyms: GDC-0941
Target:  

PI3K Autophagy Apoptosis

Research Areas:  

Cancer

Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with an IC50 of 3 nM, with modest selectivity against p110β (11-fold) and p110γ (25-fold).
loading...
    loading...
68
68 Publications Verification
Cat. No.: HY-20180
CAS No.: 957054-33-0
Synonyms: GDC-0941 dimethanesulfonate ; GDC-0941 (2 MeSO3H salt)
Target:  

PI3K Autophagy Apoptosis

Research Areas:  

Cancer

Pictilisib dimethanesulfonate (GDC-0941 dimethanesulfonate) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM, with modest selectivity against p110β (11-fold) and p110γ (25-fold).
loading...
    loading...
50
50 Cited Publications
Cat. No.: HY-10617A
CAS No.: 283173-50-2
Purity:  99.97%
Synonyms: AG014699; PF-01367338
Target:  

PARP

Research Areas:  

Cancer

Rucaparib (AG014699) is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib has the potential for castration-resistant prostate cancer (CRPC) research .
loading...
    loading...
49
49 Cited Publications
Cat. No.: HY-10617
CAS No.: 459868-92-9
Purity:  99.56%
Synonyms: AG-014699 phosphate; PF-01367338 phosphate
Target:  

PARP

Research Areas:  

Cancer

Rucaparib (AG014699) phosphate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib phosphate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib phosphate has the potential for castration-resistant prostate cancer (CRPC) research .
loading...
    loading...
41
41 Cited Publications
Cat. No.: HY-102003
CAS No.: 1859053-21-6
Purity:  99.82%
Synonyms: AG014699 monocamsylate; PF-01367338 monocamsylate
Target:  

PARP

Research Areas:  

Cancer

Rucaparib (AG014699) monocamsylate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib monocamsylate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib monocamsylate has the potential for castration-resistant prostate cancer (CRPC) research .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-12719
CAS No.: 113775-47-6
Purity:  99.93%
Synonyms: (+)-Medetomidine; (S)-Medetomidine
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease Cancer

Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects .
loading...
    loading...
32
32 Cited Publications
Cat. No.: HY-17034A
CAS No.: 145108-58-3
Synonyms: (+)-Medetomidine hydrochloride; (S)-Medetomidine hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Infection Cancer

Dexmedetomidine hydrochloride ((+)-Medetomidine hydrochloride) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine hydrochloride shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine hydrochloride exhibits anxiolysis, sedation, and modest analgesia effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15641
CAS No.: 223387-75-5
Purity:  99.46%
Synonyms: IOX3; YM311
Research Areas:  

Metabolic Disease

FG-2216 (IOX3) is a potent and orally active inhibitor of HIF prolyl hydroxylase-2 (PHD2), with an IC50 of 3.9 μM. FG-2216 induces robust erythropoietin and modest fetal hemoglobin in vivo .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15046
CAS No.: 366454-36-6
Target:  

PARP

EB-47, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM. EB-47 mimics the substrate NAD + and extends from the nicotinamide to the adenosine subsite .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-108631
CAS No.: 1190332-25-2
Purity:  99.68%
Target:  

PARP

Research Areas:  

Inflammation/Immunology

EB-47 dihydrochloride, a potent and selective PARP-1/ARTD-1 inhibitor with an IC50 value of 45 nM, shows modest potency against ARTD5 with an IC50 value of 410 nM. EB-47 mimics the substrate NAD +?and extends from the nicotinamide to the adenosine subsite .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18010
CAS No.: 330786-25-9
Target:  

Btk BCRP

Research Areas:  

Inflammation/Immunology

PCI 29732 is a potent, orally active, reversible BTK inhibitor with Ki app values of 8.2, 4.6, and 2.5 nM for BTK, Lck and Lyn, respectively. PCI 29732 shows only modest inhibitory activity against Itk, another Tec family kinase. PCI 29732 inhibits the function of ABCG2 by competitively binding to the ATP-binding site of ABCG2 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-117626
CAS No.: 1454555-29-3
Purity:  99.74%
LP-935509 is an orally active, potent, selective, ATP-competitive and brain-penetrant inhibitor of adaptor protein-2 associated kinase 1 (AAK1) with an IC50 of 3.3 nM and a Ki of 0.9 nM, respectively. LP-935509 is also a potent inhibitor of BIKE (IC50=14 nM) and a modest inhibitor of GAK (IC50=320 nM). LP-935509 shows antinociceptive activity. LP-935509 can be used for neuropathic pain and SARS-CoV-2 research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13895
CAS No.: 211555-04-3
Purity:  98.77%
Target:  

EGFR JAK Apoptosis

Research Areas:  

Cancer

WHI-P154 is a potent EGFR inhibitor, and also modestly blocks JAK3, with IC50s of 4 nM and 1.8 μM, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1618S
CAS No.: 1271728-07-4
Corticosterone-d8 is the deuterium labeled Corticosterone. Corticosterone is an adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100809
CAS No.: 6027-91-4
Purity:  99.73%
Guvacine hydrochloride is an alkaloid from the nut of Areca catechu, acts as an inhibitor of GABA transporter, and dispalys modest selectivity for cloned GABA transporters with IC50s of 14 μM (human GAT-1), 39 μM (rat GAT-1), 58 μM (rat GAT-2), 119 μM (human GAT-3), 378 μM (rat GAT-3), and 1870 μM (human BGT-3).
loading...
    loading...
Cat. No.: HY-W090292
CAS No.: 491-72-5
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

Olivetolic acid is a biosynthetic precursor of cannabinol acid (CBGA). Olivetolic acid exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome. Olivetolic acid can be used for the study of convulsion .
loading...
    loading...
Cat. No.: HY-10473
CAS No.: 355129-15-6
Purity:  99.77%
Synonyms: KB2115
Research Areas:  

Metabolic Disease Endocrinology

Eprotirome (KB2115) is a liver-selective thyroid hormone receptor (TR) agonist. KB2115 has modestly higher affinity for TRβ than for TRα. Eprotirome reduces low-density lipoprotein (LDL) cholesterol concentrations. Eprotirome can be used for dyslipidemias and obesity research .
loading...
    loading...
Cat. No.: HY-P1095
CAS No.: 745046-84-8
Synonyms: Caspase-3 Inhibitor VII
Target:  

Caspase

Ivachtin (Caspase-3 Inhibitor VII; compound 7a) is a nonpeptide, noncompetitive and reversibl caspase-3 inhibitor with an IC50 of 23 nM. Ivachtin has modest selectivity for the remaining caspases .
loading...
    loading...
Cat. No.: HY-B0102C
CAS No.: 114247-09-5
Target:  

Serotonin Transporter

Research Areas:  

Neurological Disease

(R)-Fluoxetine hydrochloride, an antidepressant, is serotonin reuptake inhibitor (SSRI). (R)-Fluoxetine hydrochloride has modest affinity at the 5-HT2A and 5-HT2C receptors .
loading...
    loading...
Cat. No.: HY-132822
CAS No.: 748119-79-1
Purity:  99.71%
Synonyms: SBP-101
Target:  

Drug Derivative

Research Areas:  

Cancer

Ivospemin (SBP-101) is an antineoplastic spermine analog. Ivospemin has shown efficacy in slowing pancreatic and ovarian tumor progression in vitro and in vivo. Ivospemin shows modest induction of polyamine catabolism, but stronger repression of ornithine decarboxylase activity. Ivospemin is promising for research of cancers .
loading...
    loading...